Variant report
Variant | nsv818086 |
---|---|
Chromosome Location | chr2:141905052-141921632 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs7583934 | chr2:141905052-141905053 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs186243192 | chr2:141905075-141905076 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs140766897 | chr2:141905078-141905079 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs199901829 | chr2:141905082-141905083 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs191486333 | chr2:141905120-141905121 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs555651985 | chr2:141905243-141905244 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs575908006 | chr2:141905258-141905259 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs544535493 | chr2:141905278-141905279 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs564506205 | chr2:141905325-141905326 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs556358718 | chr2:141905349-141905350 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs533203538 | chr2:141905353-141905354 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs540226928 | chr2:141905402-141905403 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs560249700 | chr2:141905416-141905417 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs7586992 | chr2:141905417-141905418 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs539982908 | chr2:141905426-141905427 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs559601924 | chr2:141905427-141905428 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs548788494 | chr2:141905470-141905471 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs59691536 | chr2:141905485-141905486 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs531643576 | chr2:141905522-141905523 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs141477013 | chr2:141905575-141905576 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs181506234 | chr2:141905595-141905596 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs150820644 | chr2:141905621-141905622 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs553780647 | chr2:141905637-141905638 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs58860655 | chr2:141905651-141905652 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs577778659 | chr2:141905673-141905674 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs34487055 | chr2:141906047-141906048 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs560088541 | chr2:141906057-141906058 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs150061220 | chr2:141906061-141906062 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs190692779 | chr2:141906070-141906071 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs562706503 | chr2:141906074-141906075 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs79093451 | chr2:141906090-141906091 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs12691594 | chr2:141906103-141906104 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs571478743 | chr2:141906115-141906116 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs527554302 | chr2:141906164-141906165 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs547429351 | chr2:141906178-141906179 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs558171213 | chr2:141906196-141906197 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs573479289 | chr2:141906216-141906217 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs183193248 | chr2:141906222-141906223 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs56825652 | chr2:141906223-141906224 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs569726488 | chr2:141906264-141906265 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs551431414 | chr2:141906326-141906327 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs538092615 | chr2:141906347-141906348 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs186394745 | chr2:141906374-141906375 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs577940862 | chr2:141906375-141906376 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs190705822 | chr2:141906390-141906391 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs76551404 | chr2:141906391-141906392 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs182947729 | chr2:141906416-141906417 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs201447613 | chr2:141906418-141906419 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs140187427 | chr2:141906419-141906420 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs576460399 | chr2:141906427-141906428 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Breast cancer | 16272173 | CNVD |
Mowat-Wilson syndrome | 21572526 | CNVD |
Disorders of sex development | 21048976 | CNVD |
epilepsy | 18472482 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Colorectal cancer | 16272173 | CNVD |
myoclonus epilepsy | 18472482 | CNVD |
Benign familial neonatal-infantile seizures | 18472482 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Prostate cancer | 18632612 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Mental retardation | 22214275 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Glioblastoma multiforme | 19435819 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Glioblastoma | 21080181 | CNVD |
Cancer | 22183965 | CNVD |
Melanoma | 22183965 | CNVD |
Autism | 22543975 | CNVD |
Cancer | 20164920 | CNVD |
Hypertension | 22686481 | CNVD |
Hypospadia | 22686481 | CNVD |
Intellectual disability | 22686481 | CNVD |
Omphalocele | 22686481 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Prostate cancer | 22341455 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:141904000-141905800 | Enhancers | Dnd41 | blood |
2 | chr2:141906000-141906600 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
3 | chr2:141908200-141908800 | Enhancers | Fetal Heart | heart |
4 | chr2:141908200-141910400 | Enhancers | Liver | Liver |
5 | chr2:141919800-141920600 | Enhancers | Hela-S3 | cervix |
6 | chr2:141920000-141920600 | Enhancers | iPS-20b Cell Line | embryonic stem cell |